Early blood test can predict treatment response and survival prospects in metastatic prostate cancer

FHS
October 7, 2024
11:45 pm

A blood test, performed when metastatic prostate cancer is first diagnosed, can predict which patients are likely to respond to treatment and survive the longest.

Gubernatorial candidates quarrel over glory for winning opioid settlements

Opioid settlement cash is not inherently political. It’s not the result of a law passed by Congress nor an edit to the state budget. It’s

November 1, 2023

Christopher J. Moreau | Chief Executive Officer, Algernon Pharmaceuticals | Psychedelic Finance

Mr. Moreau is a seasoned business professional in the life sciences sector with a strong background in biotechnology research, business development and a deep expertise

July 7, 2023

Government unveils a £600 million package to help with recruitment in social care

The government has today unveiled a £600 million package to help with recruitment and retention in social care. The fund will support the social care

July 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.